Monika Tomaszewska-Kiecana

Biokinetica S.A.
Jozefow, Poland

-

Disclosure information not submitted.

Presentation(s):

• 1421: Pharmacokinetics, Safety, Tolerability, and Immunogenicity of a Proposed Tocilizumab Biosimilar (MSB11456) versus US‑licensed Tocilizumab: Results of a Randomized, Double-blind, Parallel‑group, Single‑intravenous Dose Study in Healthy Adults (APTURA II)

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time